about
Optic neuritis as isolated manifestation of leptomeningeal carcinomatosis: a case report and systematic review of ocular manifestations of neoplastic meningitisAntibody biomarkers in CNS demyelinating diseases - a long and winding roadDelayed diagnosis, range of severity, and multiple sleep comorbidities: a clinical and polysomnographic analysis of 100 patients of the innsbruck narcolepsy cohort.Sensitivity and specificity of diagnostic accuracy in Alzheimer's disease: a synthesis of existing evidence.Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob diseaseAssociation of lipocalin-type prostaglandin D synthase with disproportionately enlarged subarachnoid-space in idiopathic normal pressure hydrocephalus.Neurofilaments as biomarkers in multiple sclerosis.Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis.Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury.Neoplastic leptomeningeal disease masquerading as central serous retinopathy. A case report.Progressive Stroke-Like Symptoms in a Patient with Sporadic Creutzfeldt-Jakob Disease.Defining active progressive multiple sclerosis.Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.Intrathecal immunoglobulin synthesis in patients with symptomatic epilepsy and epilepsy of unknown etiology ('cryptogenic').Post-seizure α-tocopherol treatment decreases neuroinflammation and neuronal degeneration induced by status epilepticus in rat hippocampus.Effects of ferrofluid and phytoalexin spirobrassinin on thioflavin-T-based fluorescence in cerebrospinal fluid of the elderly and multiple sclerosis patients.Rapidly Progressing Sporadic Creutzfeldt-Jakob Disease Presenting as a StrokeCerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementiasShort commentary on ‘a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking’
P2860
Q27001030-D5BC638C-BA4D-4CA8-8D0E-DA0220527954Q28262403-BA67C001-1593-49AC-9D8D-CBEACC029E33Q30443031-1688E66A-0742-4718-AB9C-07664B2C2483Q34728483-3522A7AF-642F-4160-8EB4-E7990D9B7AFFQ35000781-A1B9F366-2AE9-4167-8596-BF2E37C51A26Q35297556-3814DA22-B19F-4BD4-A817-4C51EA733899Q37710507-7E91E593-07D7-456F-9AEC-B8544CE42610Q38001602-F7308CCF-A4DA-4A77-BF6B-F6D9D418268CQ38782456-B04554E8-1B4D-4150-A5D4-12AF13DD16D3Q39628369-A2E83BA8-DEFD-4C80-A2B2-AFE54355675EQ42322973-0AAAF0FC-BB3A-48AE-9D54-889A74DC5435Q42593346-966FA713-EE84-4942-B83E-A5102BF66B6DQ47918387-E1C1A480-573D-4AFB-AAC0-F22D37D4E3E2Q48006195-E04F2171-D74A-4E4A-BF53-32B4367F0781Q48175984-64450C4A-8B83-43A1-8719-AD1203F348FEQ51755394-87C63299-9CC7-4699-B9F7-1F1CF3890F3EQ53352976-3019B39F-9BFF-4C25-8891-48AE4E6B5A88Q57493499-F9289FB7-990A-4507-BBA7-8FF6A480BA8FQ57750814-F79C17C3-A32F-4A27-8784-1FB47C60E202Q59280141-7E90062B-0C87-4A85-90C8-E7C8F915B538
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
EFNS guidelines on disease-specific CSF investigations.
@en
EFNS guidelines on disease-specific CSF investigations.
@nl
type
label
EFNS guidelines on disease-specific CSF investigations.
@en
EFNS guidelines on disease-specific CSF investigations.
@nl
prefLabel
EFNS guidelines on disease-specific CSF investigations.
@en
EFNS guidelines on disease-specific CSF investigations.
@nl
P2093
P2860
P1476
EFNS guidelines on disease-specific CSF investigations.
@en
P2093
F Deisenhammer
F Sellebjerg
P2860
P304
P356
10.1111/J.1468-1331.2009.02595.X
P577
2009-06-01T00:00:00Z